OBJECTIVE: To determine the management of @entity1 with new onset @entity2210 by Canadian family physicians. METHODS: A survey was mailed to 195 family physicians in August 1995 to identify how they manage @entity2210 in @entity1 according to four scenarios: based on presenting symptoms alone; assuming @entity1534 -positive; known to be @entity1534 -negative; and endoscopically confirmed @entity2210 . RESULTS: A total of 170 of 195 physicians (87.2%) completed the survey. Physicians reported that 7.3% of their practice is devoted to @entity2210 and 23% of these dyspeptic @entity1 present for the first time. Ninety-three per cent of family physicians find a symptom classification of ulcer-, reflux- and @entity4423 -like @entity2210 helpful. The majority of @entity1 are advised to make life-style changes and are treated with antacids or empiric drug therapy. A H2 receptor antagonist was the drug of choice for @entity1066 , while prokinetics were often used for reflux and @entity4423 -like @entity2210 . After failure of initial treatment, @entity1 were given another course of empiric treatment, commonly with @entity4392 or @entity4546 . Family physicians estimated that the mean time to obtain a gastrointestinal consult was five weeks, and 70% indicated that this time to consult adversely influenced their decision to refer. If this time was reduced to less than two weeks, responding physicians would consider referring all eligible @entity1 . On average, two to 2.5 courses of empiric therapy were given before referral. If @entity1534 status was known, fewer empiric treatments (mean 1.8) were given before gastroenterological referral compared with the other scenarios. If the @entity1 had @entity2210 , 30% of family physicians provided reassurance only and did not prescribe empiric drug treatment. CONCLUSIONS: Most newly dyspeptic @entity1 in Canada are treated with empiric therapy according to symptom classification and referred for endoscopy after an average two to 2.5 treatment courses.

A Canadian physician survey of XXXX management.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity4392 :: ('MESH:D020117', 'Chemical') :: ['cisapride'] @entity1066 :: ('MESH:D014456', 'Disease') :: ['ulcer and reflux-like dyspepsia'] @entity1534 :: ('210', 'Species') :: ['H pylori', 'Helicobacter pylori'] @entity2210 :: ('MESH:D004415', 'Disease') :: ['dyspepsia', 'nonulcer dyspepsia'] @entity4423 :: ('MESH:D015154', 'Disease') :: ['dysmotility'] @entity4546 :: ('MESH:D009853', 'Chemical') :: ['omeprazole']
@entity2210 :: (MESH:D004415,Disease) :: ['dyspepsia']
